Castro, Betsy E.; Berrio, Maritza; Vargas, Monica L.; Carvajal, Lina P.; Millan, Lina V.; Rios, Rafael; Hernandez, Angie K.; Rincon, Sandra; Cubides, Paola; Forero, Erika; Dinh, An; Seas Ramos, Carlos Rafael; Munita, Jose M.; Arias, Cesar A.; Reyes, Jinnethe; Diaz, Lorena
(Oxford University Press, 2020)
BACKGROUND: Vancomycin is a common first-line option for MRSA infections. The heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) phenotype is associated with therapeutic failure. However, hVISA isolates ...